Cargando…

Modeling Myotonic Dystrophy Type 2 Using Drosophila melanogaster

Myotonic dystrophy 2 (DM2) is a genetic multi-systemic disease primarily affecting skeletal muscle. It is caused by CCTGn expansion in intron 1 of the CNBP gene, which encodes a zinc finger protein. DM2 disease has been successfully modeled in Drosophila melanogaster, allowing the identification and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marzullo, Marta, Coni, Sonia, De Simone, Assia, Canettieri, Gianluca, Ciapponi, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532015/ https://www.ncbi.nlm.nih.gov/pubmed/37762484 http://dx.doi.org/10.3390/ijms241814182

Ejemplares similares

Modeling of Myotonic Dystrophy Cardiac Phenotypes in Drosophila
por: Chakraborty, Mouli, et al.
Publicado: (2018)

Translational control of polyamine metabolism by CNBP is required for Drosophila locomotor function
por: Coni, Sonia, et al.
Publicado: (2021)

Development of a Drosophila melanogaster spliceosensor system for in vivo high-throughput screening in myotonic dystrophy type 1
por: García-Alcover, Irma, et al.
Publicado: (2014)

Dissecting Pathogenetic Mechanisms and Therapeutic Strategies in Drosophila Models of Myotonic Dystrophy Type 1
por: Souidi, Anissa, et al.
Publicado: (2018)

Myotonic dystrophy
por: Patterson, VH
Publicado: (1990)

Marathoning with myotonic dystrophy type 2 (proximal myotonic myopathy) and leukopenia
por: Finsterer, Josef, et al.
Publicado: (2017)

TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2
por: Bosè, Francesca, et al.
Publicado: (2019)

Targeting Myotonic Dystrophy Type 1 with Metformin
por: García-Puga, Mikel, et al.
Publicado: (2022)

Increased autophagy and apoptosis contribute to muscle atrophy in a myotonic dystrophy type 1 Drosophila model
por: Bargiela, Ariadna, et al.
Publicado: (2015)

Reducing the Excess Activin Signaling Rescues Muscle Degeneration in Myotonic Dystrophy Type 2 Drosophila Model
por: Deng, Jing, et al.
Publicado: (2022)

Overexpression of CUGBP1 in Skeletal Muscle from Adult Classic Myotonic Dystrophy Type 1 but Not from Myotonic Dystrophy Type 2
por: Cardani, Rosanna, et al.
Publicado: (2013)

Cancer and Myotonic Dystrophy
por: D’Ambrosio, Eleonora S., et al.
Publicado: (2023)

Muscleblind, BSF and TBPH are mislocalized in the muscle sarcomere of a Drosophila myotonic dystrophy model
por: Llamusi, Beatriz, et al.
Publicado: (2013)

Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction
por: Chakraborty, Mouli, et al.
Publicado: (2015)

Disease burden of myotonic dystrophy type 1
por: Landfeldt, Erik, et al.
Publicado: (2019)

Myotonic dystrophy type 2: the 2020 update
por: Meola, Giovanni
Publicado: (2020)

Cardiac Pathology in Myotonic Dystrophy Type 1
por: Mahadevan, Mani S., et al.
Publicado: (2021)

Dysregulation of Circular RNAs in Myotonic Dystrophy Type 1
por: Voellenkle, Christine, et al.
Publicado: (2019)

Fuchs' Endothelial Corneal Dystrophy in Patients With Myotonic Dystrophy, Type 1
por: Winkler, Nelson S., et al.
Publicado: (2018)

Cells of Matter—In Vitro Models for Myotonic Dystrophy
por: Matloka, Magdalena, et al.
Publicado: (2018)

Desflurane anaesthesia in myotonic dystrophy
por: Gandhi, Ranju, et al.
Publicado: (2011)

Myotonic Dystrophy: An Anaesthetic Dilemma
por: Gupta, N, et al.
Publicado: (2009)

Cardiac involvement in myotonic dystrophy
por: Khalighi, Koroush, et al.
Publicado: (2015)

Steakhouse Syndrome in Myotonic Dystrophy
por: Ogasawara, Nobuhiko, et al.
Publicado: (2017)

Cutaneous findings in myotonic dystrophy
por: Kong, Ha Eun, et al.
Publicado: (2022)

Small Molecules Which Improve Pathogenesis of Myotonic Dystrophy Type 1
por: López-Morató, Marta, et al.
Publicado: (2018)

(CCUG)(n) RNA toxicity in a Drosophila model of myotonic dystrophy type 2 (DM2) activates apoptosis
por: Yenigun, Vildan Betul, et al.
Publicado: (2017)

Myotonic Dystrophy Type 1 Presenting as Male Infertility
por: Kim, Woong Bin, et al.
Publicado: (2012)

Deregulated MicroRNAs in Myotonic Dystrophy Type 2
por: Greco, Simona, et al.
Publicado: (2012)

Hypogonadism and erectile dysfunction in myotonic dystrophy type 1
por: PERIC, STOJAN, et al.
Publicado: (2013)

Prevalence and correlates of apathy in myotonic dystrophy type 1
por: Gallais, Benjamin, et al.
Publicado: (2015)

Imaging in Myotonic Dystrophy Type 1 – Case Reports
por: Bielen, Jurgen, et al.
Publicado: (2016)

Metabolic impairments in patients with myotonic dystrophy type 2
por: VUJNIC, MILORAD, et al.
Publicado: (2018)

Personality traits in patients with myotonic dystrophy type 2
por: Paunic, Teodora, et al.
Publicado: (2017)

Responsiveness of outcome measures in myotonic dystrophy type 1
por: Knak, Kirsten L., et al.
Publicado: (2020)

Endometriosis as Initial Manifestation of Myotonic Dystrophy Type-2
por: Finsterer, Josef, et al.
Publicado: (2021)

Basilar Artery Dissection in Myotonic Dystrophy Type 1
por: Lee, Chan-Hyuk, et al.
Publicado: (2022)

Benefits of aerobic exercise in myotonic dystrophy type 1
por: Mackenzie, Samuel J., et al.
Publicado: (2022)

Autoimmune Diseases in Patients With Myotonic Dystrophy Type 2
por: Peric, Stojan, et al.
Publicado: (2022)

Myotonic dystrophy type 1 in the COVID-19 era
por: Ilic Zivojinovic, Jelena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_00itj8f9tqdth80dg16of7nvda